Browsing by Author Balabanska, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
Hepatitis B virus antigen reduction effect of RO7049389 plus NUC with/without Peg-IFN in chronic hepatitis B patients. Poster Presentation (THU408)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Hou, JLGane, EJZhang, WHZhang, JMYuen, RMFLim, THBalabanska, RXie, QKomolmit, PLiang, XZhang, WZhou, XXue, ZHTriyatni, MChen, EZhang, YCBo, QY
2022
 
TLR7 agonist ro7020531 triggers immune activation after multiple doses in chronic hepatitis B patients
Proceeding/Conference:Hepatology
Gane, EJAgarwai, KBalabanska, RZhu, YLu, GGrippo, JFJin, YTriyatni, MFolitar, IUpmanyu, RGlavini, KCoakley, ERacek, TYuen, RMF
2018
 
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial
Journal:The Lancet Infectious Diseases
Yuen, MFBalabanska, RCottreel, EChen, ETDuan, DJiang, QDPatil, ATriyatni, MUpmanyu, RZhu, YHCanducci, FGane, EJ
22-Mar-2023
 
Viral nucleic acids suppression activity of RO7049389 plus NUC with/without Peg-IFN in virologically-suppressed and naive chronic hepatitis B patients: 48-week treatment and posttreatment follow-up. Poster Presentation (SAT427)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Yuen, RMFBalabanska, RHou, JLGane, EJLim, THZhang, WHXie, QKomolmit, PLeerapun, AYang, S-SYeh, C-TZhang, WZhou, XXue, ZHTriyatni, MChen, ELi, RBo, Q-Y
2022
Showing results 1 to 4 of 4